Clinical Trials · NCT07127315
Assessing Gonadotropin-Releasing Hormone Agonists Benefit in Preserving the Ovarian Function in Premenopausal Breast Cancer Patients During Chemotherapy
- Phase
- N/A
- Recruitment status
- Completed
- Sponsor
- Helwan University
- Enrollment
- 100
- Start date
- Jul 2022
- Locations
- 1 site, Egypt
- Primary endpoint
- Anti-mullerian hormone level